Introduction: As the world battles to combat the spread of COVID-19, there is need to ensure the availability of blood and blood products for the population of sick individuals who need them. Doctors and other health workers are often faced with the challenges of providing safe b...
Chiemelie Raluchukwu Onwasigwe, Michael Chidiebele Egolum, Angela Ogechukwu Ugwu & Hector Okechukwu Obianyido·International Blood Research & Reviews·2026
Background: Non-Hodgkin lymphoma is a heterogeneous group of lymphoid malignancies with variable clinical behaviour and treatment outcomes. In resource-constrained settings, limited access to advanced prognostic investigations increases the need for simple biomarkers. This study...
Open access
Research Article10.9734/ibrr/2026/v17i3389
Background: The prevalence of Non-Hodgkin lymphoma (NHL) has waxed and waned with the trends in HIV prevalence over the years. The clinical landscape as well as treatment experience in Africa has not earned the much needed attention. Aim: This study aimed at giving insight to the...